OGN vs POCI · P/E 3.4, rev $3.02B vs rev $19.1M
Organon & Co (OGN) versus Precision Optics Corporation, Inc. Common stock (POCI) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Precision Optics Corporation, Inc. Common stock (POCI) is a medical instruments & supplies company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported POCI revenue for 2025-06-30 was $19.1M. Net income was -$5.8M. POCI currently screens at market cap $63.4M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. POCI currently screens at market cap $63.4M.
Not investment advice. Open the OGN and POCI stock pages for the full models.
Not investment advice.